TipRanks on MSN

4D Molecular Therapeutics expands phase 3 trial enrollment

D Molecular Therapeutics ( ($FDMT) ) has shared an update. On December 10, 2025, 4D Molecular Therapeutics announced amendments to its Phase 3 ...
Yahoo Finance

4D Molecular Therapeutics Reports Full Year 2021 Financial Results and Operational Highlights

EMERYVILLE, Calif., March 28, 2022 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT), a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted ...